All Stories

  1. A deep dive into atrial fibrillation in chronic obstructive pulmonary disease
  2. Assessment of Comorbidities in Chronic Obstructive Pulmonary Disease Patients by Chest High Resolution Computed Tomography (HRCT)
  3. Ensuring patient safety: a closer look at glucocorticoid therapy in COPD and asthma
  4. COPD and Cardiovascular Diseases: Biomarker-Guided Stratification and Therapeutic Perspectives
  5. Clinical and immunological assessment of thyroid pathology in rheumatoid arthritis
  6. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  7. Patients with sickle cell disease and asthma have a higher risk for acute chest syndrome: A systematic review and meta‑analysis of observational studies
  8. Impact of urogenital and enterocolitic infections on the onset and evolution of ankylosing spondylitis and psoriatic arthritis
  9. Chronic obstructive pulmonary disease (COPD) and autoimmune diseases: unravelling complex interactions
  10. The Hidden Burden of COMISA: Clinical Implications and Treatment Challenges
  11. Burden of ophthalmologic disorders in obstructive sleep apnea
  12. Diagnostic and management controversies in ANCA-associated interstitial lung diseases
  13. Fungal allergy - features of molecular diagnosis
  14. Cardiopulmonary exercise testing in chronic obstructive pulmonary disease
  15. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study...
  16. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
  17. Potential of doxofylline in the treatment of chronic obstructive airway diseases (Review)
  18. The impact of comorbidities on chronic obstructive pulmonary disease
  19. Tuberculosis in new cases: the impact of HIV status on clinical manifestations
  20. Comparative analysis of clinical characteristics of gout patients
  21. Chronic Obstructive Pulmonary Disease and Depression—The Vicious Mental Cycle
  22. Broad Electrocardiogram Syndromes Spectrum: From Common Emergencies to Particular Electrical Heart Disorders—Part II
  23. Diurnal variation in spirometry parameters of patients with chronic obstructive pulmonary disease: A systematic review and meta‑analysis
  24. Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023
  25. Metabolic storm in psoriatic arthritis: a cardiovascular time bomb?
  26. Diagnostic tools in respiratory medicine (Review)
  27. COPD and Depression—The Vicious Mental Cycle
  28. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  29. Weltweite Perspektiven von Krankenhauspatienten zum Einsatz von künstlicher Intelligenz im Gesundheitswesen: Ergebnisse der COMFORT-Studie aus 74 Krankenhäusern in 43 Ländern
  30. Challenges of Pediatric Tuberculosis Under Current Conditions
  31. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  32. Global cross-sectional student survey on AI in medical, dental, and veterinary education and practice at 192 faculties
  33. Assessment of comorbidities in COPD patients by chest HRCT
  34. Endobronchial foreign bodies in pediatric work – history and clinical signs suggestive of diagnosis
  35. Sarcoidosis and cancer - a diagnostic dilema
  36. Multinational attitudes towards AI in healthcare and diagnostics among hospital patients
  37. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  38. Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity
  39. Particularities of comorbidities in nonalcoholic fatty liver disease according to gender groups
  40. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  41. Editorial: Treatment of comorbidities of asthma and its safety
  42. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
  43. Hypersensitivity Pneumonitis: Challenges of a Complex Disease
  44. Medical students’ perceptions towards artificial intelligence in education and practice: A multinational, multicenter cross-sectional study
  45. Israel−Palestine Conflict: Risk of Sleep Disorders and Post-Traumatic Stress Disorders
  46. Promising treatment biomarkers in asthma
  47. Complications of tracheobronchial foreign body aspiration in children
  48. Phenotypes in adult patients with bronchiectasis: a cluster analysis
  49. The Burden of Comorbidities in Obstructive Sleep Apnea
  50. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
  51. Prevalence and Burden of Comorbidities in Obstructive Sleep Apnea Syndrome
  52. Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
  53. Updates in screening for tuberculosis. Review of guidelines
  54. Diagnostic challenges of a rare disease with an unusual presentation
  55. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review
  56. Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
  57. COPD and Diabetes Mellitus: Down the Rabbit Hole
  58. Scientists Against War: A Plea to World Leaders for Better Governance
  59. COPD and comorbidities in the Republic of Moldova
  60. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
  61. Asthma and obstructive sleep apnoea in adults and children – an up-to-date review
  62. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  63. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review
  64. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea
  65. Multidimensional indices in the assessment of chronic obstructive pulmonary disease
  66. Asthma-COPD Overlap: A more Simplistic Approach
  67. Chronic obstructive disease and comorbidities (literature review)
  68. Current Approaches to Asthma In 2021
  69. A rare case of intrathymic epidermoid cyst
  70. Asthma and stroke: a narrative review
  71. Adenoid hypertrophy can impact craniofacial growth and lead to obstructive sleep apnea in children
  72. Coenzyme Q10 suplement in chronic obstructive pulmonary disease
  73. Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
  74. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  75. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  76. Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
  77. Current Approaches to COPD in 2019
  78. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”
  79. Spontaneous Pneumomediastinum – a Rare Asthma Complication
  80. Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
  81. Identification of clinical phenotypes using cluster analyses in COPD patients
  82. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
  83. A MULTILATERAL APPROACH TO COPD COMORBIDITIES
  84. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  85. COPD and Stroke
  86. Health-related quality of life in different phenotypes of COPD
  87. Assessment of health-related quality of life in different phenotypes of COPD
  88. Bode index in different phenotypes of COPD
  89. To sleep, or not to sleep?
  90. ACOS: current evidence and future research directions
  91. Phenotyping Before Starting Treatment in COPD?
  92. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  93. Exercise-Induced Pulmonary Edema in Athletes
  94. Editorial: "COPD: More than a Moving Target!"
  95. P51 Clinical effectiveness of procalcitonin based protocols to guide the administration of antibiotics in patients presenting with COPD exacerbations: systematic review and meta-analysis
  96. Prevalence and burden of comorbidities in COPD
  97. Meet Our Assistant Editor
  98. Overview of the translocation of rupestrian ferruginous fields of Capão Xavier mine to the Serra do Rola Moça State Park, Minas Gerais – Brazil
  99. Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
  100. Health-Related Quality of Life in Patients with COPD
  101. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  102. Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
  103. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  104. Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
  105. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  106. Management of Stable COPD: An Update
  107. Breast cancer local recurrence under the form of inflammatory carcinoma, treated with concurrent radiation and chemotherapy, a case report
  108. Defining COPD
  109. Imaging for diagnosis and management of tuberculosis